close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Taiho Oncology, Inc.

News headline image
Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma
From Taiho Oncology, Inc.
Via Business Wire
News headline image
Taiho Oncology Announces New England Journal of Medicine Publication of First All-Oral Regimen in Newly Diagnosed Acute Myeloid Leukemia
From Taiho Oncology, Inc.
Via Business Wire
News headline image
U.S. FDA Approves INQOVI® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy
From Taiho Oncology, Inc.
Via Business Wire
News headline image
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
From Taiho Oncology, Inc.
Via Business Wire
Tickers CGEM
News headline image
Taiho Oncology Appoints Peter Melnyk as President & Chief Executive Officer
From Taiho Oncology, Inc.
Via Business Wire
News headline image
Peter Melnyk Joins Taiho Oncology as President & Chief Operating Officer
From Taiho Oncology, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.